nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Prednisone—Crohn's disease	0.946	1	CpDpCtD
Methylergometrine—HTR2A—enteric nervous system—Crohn's disease	0.00314	0.407	CbGeAlD
Methylergometrine—HTR2A—myenteric nerve plexus—Crohn's disease	0.00238	0.309	CbGeAlD
Methylergometrine—HTR2B—smooth muscle tissue—Crohn's disease	0.000427	0.0554	CbGeAlD
Methylergometrine—HTR2B—skin of body—Crohn's disease	0.000422	0.0547	CbGeAlD
Methylergometrine—HTR2B—digestive system—Crohn's disease	0.000337	0.0438	CbGeAlD
Methylergometrine—HTR2A—epithelium—Crohn's disease	0.000237	0.0307	CbGeAlD
Methylergometrine—HTR2A—smooth muscle tissue—Crohn's disease	0.000228	0.0296	CbGeAlD
Methylergometrine—HTR2B—lymph node—Crohn's disease	0.000193	0.025	CbGeAlD
Methylergometrine—HTR2A—digestive system—Crohn's disease	0.00018	0.0234	CbGeAlD
Methylergometrine—CYP3A4—digestive system—Crohn's disease	0.000167	0.0216	CbGeAlD
Methylergometrine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	7.03e-05	0.00152	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CCR6—Crohn's disease	7.02e-05	0.00152	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—RASGRP1—Crohn's disease	6.98e-05	0.00151	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ACKR2—Crohn's disease	6.98e-05	0.00151	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CCR9—Crohn's disease	6.9e-05	0.00149	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GPR65—Crohn's disease	6.84e-05	0.00148	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—IL3—Crohn's disease	6.81e-05	0.00147	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—GPR65—Crohn's disease	6.81e-05	0.00147	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	6.8e-05	0.00147	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MLN—Crohn's disease	6.62e-05	0.00143	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—RASGRP1—Crohn's disease	6.59e-05	0.00142	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ACKR2—Crohn's disease	6.58e-05	0.00142	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	6.58e-05	0.00142	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL3—Crohn's disease	6.56e-05	0.00142	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—GPR65—Crohn's disease	6.41e-05	0.00139	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—RASGRP1—Crohn's disease	6.34e-05	0.00137	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	6.27e-05	0.00136	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCR9—Crohn's disease	6.26e-05	0.00135	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MLN—Crohn's disease	6.24e-05	0.00135	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL3—Crohn's disease	6.18e-05	0.00134	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—PTGER4—Crohn's disease	6.18e-05	0.00134	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TAGAP—Crohn's disease	6.05e-05	0.00131	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCR9—Crohn's disease	5.99e-05	0.00129	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—RASGRP1—Crohn's disease	5.98e-05	0.00129	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—GPR65—Crohn's disease	5.82e-05	0.00126	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TAGAP—Crohn's disease	5.71e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CCR6—Crohn's disease	5.66e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ACKR2—Crohn's disease	5.63e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—GPR65—Crohn's disease	5.57e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—CXCL8—Crohn's disease	5.49e-05	0.00119	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR9—Crohn's disease	5.44e-05	0.00118	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CCR6—Crohn's disease	5.34e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MLN—Crohn's disease	5.34e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.31e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RSPO3—Crohn's disease	5.29e-05	0.00114	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	5.18e-05	0.00112	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—CXCL8—Crohn's disease	5.18e-05	0.00112	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCR6—Crohn's disease	5.16e-05	0.00112	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCR6—Crohn's disease	5.14e-05	0.00111	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	5.06e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—IL2RA—Crohn's disease	5.06e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GPR65—Crohn's disease	5.06e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SEL1L—Crohn's disease	5.01e-05	0.00108	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RSPO3—Crohn's disease	4.99e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—PTGER4—Crohn's disease	4.98e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	4.97e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ACKR2—Crohn's disease	4.89e-05	0.00106	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TAGAP—Crohn's disease	4.88e-05	0.00106	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCR6—Crohn's disease	4.87e-05	0.00105	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCR6—Crohn's disease	4.85e-05	0.00105	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—IL2RA—Crohn's disease	4.77e-05	0.00103	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SEL1L—Crohn's disease	4.73e-05	0.00102	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—PTGER4—Crohn's disease	4.7e-05	0.00102	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RBX1—Crohn's disease	4.67e-05	0.00101	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MLN—Crohn's disease	4.63e-05	0.001	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	4.61e-05	0.000996	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL2RA—Crohn's disease	4.59e-05	0.000993	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR9—Crohn's disease	4.59e-05	0.000992	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CCR6—Crohn's disease	4.57e-05	0.000988	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PTGER4—Crohn's disease	4.55e-05	0.000983	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PTGER4—Crohn's disease	4.53e-05	0.000979	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RBX1—Crohn's disease	4.41e-05	0.000953	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.4e-05	0.00095	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL2RA—Crohn's disease	4.33e-05	0.000937	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR9—Crohn's disease	4.32e-05	0.000935	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PTGER4—Crohn's disease	4.29e-05	0.000927	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PTGER4—Crohn's disease	4.27e-05	0.000923	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RSPO3—Crohn's disease	4.27e-05	0.000923	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GPR65—Crohn's disease	4.26e-05	0.000922	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—IL3—Crohn's disease	4.25e-05	0.000918	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.24e-05	0.000917	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TAGAP—Crohn's disease	4.24e-05	0.000917	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCR6—Crohn's disease	4.15e-05	0.000897	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—RASGRP1—Crohn's disease	4.11e-05	0.000888	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—UBE2D1—Crohn's disease	4.09e-05	0.000885	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SEL1L—Crohn's disease	4.04e-05	0.000875	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PTGER4—Crohn's disease	4.02e-05	0.00087	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GPR65—Crohn's disease	4.02e-05	0.000869	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—IL3—Crohn's disease	4e-05	0.000866	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4e-05	0.000865	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RIPK2—Crohn's disease	3.97e-05	0.000859	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCR6—Crohn's disease	3.97e-05	0.000858	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	3.87e-05	0.000837	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL3—Crohn's disease	3.87e-05	0.000837	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—UBE2D1—Crohn's disease	3.86e-05	0.000835	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL3—Crohn's disease	3.86e-05	0.000834	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RIPK2—Crohn's disease	3.75e-05	0.00081	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RASGRP1—Crohn's disease	3.75e-05	0.00081	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—RASGRP1—Crohn's disease	3.73e-05	0.000806	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RSPO3—Crohn's disease	3.7e-05	0.000801	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR9—Crohn's disease	3.7e-05	0.0008	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL3—Crohn's disease	3.65e-05	0.00079	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PTGER4—Crohn's disease	3.65e-05	0.00079	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL3—Crohn's disease	3.64e-05	0.000786	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.61e-05	0.00078	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	3.6e-05	0.000779	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RASGRP1—Crohn's disease	3.53e-05	0.000764	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—RASGRP1—Crohn's disease	3.52e-05	0.00076	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	3.51e-05	0.000759	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	3.49e-05	0.000755	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GPR65—Crohn's disease	3.44e-05	0.000744	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—IL3—Crohn's disease	3.43e-05	0.000741	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.42e-05	0.00074	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—JAK2—Crohn's disease	3.4e-05	0.000735	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SOCS1—Crohn's disease	3.39e-05	0.000734	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—RASGRP1—Crohn's disease	3.31e-05	0.000716	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—TYK2—Crohn's disease	3.24e-05	0.0007	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—CXCL8—Crohn's disease	3.23e-05	0.000698	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.22e-05	0.000695	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR9—Crohn's disease	3.21e-05	0.000695	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—JAK2—Crohn's disease	3.21e-05	0.000693	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—IL6—Crohn's disease	3.2e-05	0.000692	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SOCS1—Crohn's disease	3.2e-05	0.000692	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	3.17e-05	0.000686	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL3—Crohn's disease	3.11e-05	0.000673	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—CXCL8—Crohn's disease	3.1e-05	0.000671	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—JAK2—Crohn's disease	3.09e-05	0.000667	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—TYK2—Crohn's disease	3.05e-05	0.00066	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—CXCL8—Crohn's disease	3.04e-05	0.000658	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR6—Crohn's disease	3.04e-05	0.000657	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	3.01e-05	0.000651	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GPR65—Crohn's disease	2.99e-05	0.000646	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	2.97e-05	0.000643	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—IL2RA—Crohn's disease	2.97e-05	0.000643	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.97e-05	0.000642	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SMAD3—Crohn's disease	2.93e-05	0.000633	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CXCL8—Crohn's disease	2.93e-05	0.000633	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.91e-05	0.00063	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—JAK2—Crohn's disease	2.91e-05	0.00063	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	2.88e-05	0.000622	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR6—Crohn's disease	2.86e-05	0.000619	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CXCL8—Crohn's disease	2.82e-05	0.000609	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—IL2RA—Crohn's disease	2.8e-05	0.000607	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SMAD3—Crohn's disease	2.76e-05	0.000598	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RBX1—Crohn's disease	2.75e-05	0.000594	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL2RA—Crohn's disease	2.71e-05	0.000587	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL3—Crohn's disease	2.7e-05	0.000584	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL2RA—Crohn's disease	2.7e-05	0.000584	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTGER4—Crohn's disease	2.67e-05	0.000578	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CXCL8—Crohn's disease	2.66e-05	0.000575	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	2.61e-05	0.000565	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	2.6e-05	0.000563	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.59e-05	0.000561	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RBX1—Crohn's disease	2.59e-05	0.00056	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL2RA—Crohn's disease	2.56e-05	0.000553	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL2RA—Crohn's disease	2.55e-05	0.000551	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTGER4—Crohn's disease	2.52e-05	0.000545	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR6—Crohn's disease	2.45e-05	0.00053	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—UBE2D1—Crohn's disease	2.41e-05	0.000521	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	2.4e-05	0.000519	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RIPK2—Crohn's disease	2.34e-05	0.000505	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL3—Crohn's disease	2.28e-05	0.000493	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—UBE2D1—Crohn's disease	2.27e-05	0.000491	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	2.26e-05	0.000489	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.25e-05	0.000487	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RBX1—Crohn's disease	2.22e-05	0.000479	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RASGRP1—Crohn's disease	2.2e-05	0.000476	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RIPK2—Crohn's disease	2.2e-05	0.000476	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	2.18e-05	0.000471	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	2.16e-05	0.000467	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL3—Crohn's disease	2.15e-05	0.000464	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR6—Crohn's disease	2.13e-05	0.00046	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	2.08e-05	0.000451	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RASGRP1—Crohn's disease	2.08e-05	0.000449	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	2e-05	0.000432	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	2e-05	0.000432	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.96e-05	0.000425	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	1.94e-05	0.00042	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RBX1—Crohn's disease	1.92e-05	0.000416	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TYK2—Crohn's disease	1.91e-05	0.000413	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	1.9e-05	0.000412	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	1.89e-05	0.000409	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	1.89e-05	0.000408	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	1.88e-05	0.000407	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SOCS1—Crohn's disease	1.88e-05	0.000407	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	1.87e-05	0.000405	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL3—Crohn's disease	1.84e-05	0.000397	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	1.82e-05	0.000395	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—JAK2—Crohn's disease	1.82e-05	0.000394	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	1.82e-05	0.000393	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TYK2—Crohn's disease	1.8e-05	0.00039	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TYK2—Crohn's disease	1.79e-05	0.000388	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	1.78e-05	0.000384	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	1.72e-05	0.000373	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	1.72e-05	0.000372	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—JAK2—Crohn's disease	1.72e-05	0.000372	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—JAK2—Crohn's disease	1.71e-05	0.00037	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	1.69e-05	0.000365	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.67e-05	0.000361	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCL8—Crohn's disease	1.66e-05	0.00036	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	1.66e-05	0.000358	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	1.64e-05	0.000354	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SMAD3—Crohn's disease	1.63e-05	0.000351	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	1.61e-05	0.000349	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	1.61e-05	0.000348	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL3—Crohn's disease	1.6e-05	0.000345	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	1.6e-05	0.000345	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—Crohn's disease	1.58e-05	0.000342	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCL8—Crohn's disease	1.57e-05	0.000339	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	1.56e-05	0.000338	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	1.54e-05	0.000334	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	1.54e-05	0.000332	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	1.5e-05	0.000325	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—Crohn's disease	1.49e-05	0.000323	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	1.47e-05	0.000318	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	1.46e-05	0.000317	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	1.4e-05	0.000303	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	1.4e-05	0.000302	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	1.39e-05	0.000301	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—STAT3—Crohn's disease	1.34e-05	0.000289	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	1.34e-05	0.000289	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	1.33e-05	0.000288	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—FADS1—Crohn's disease	1.3e-05	0.000281	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	1.29e-05	0.000278	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.28e-05	0.000276	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	1.27e-05	0.000275	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STAT3—Crohn's disease	1.26e-05	0.000273	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPX4—Crohn's disease	1.22e-05	0.000264	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	1.21e-05	0.000261	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GCKR—Crohn's disease	1.18e-05	0.000255	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	1.16e-05	0.000251	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TYK2—Crohn's disease	1.12e-05	0.000243	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	1.12e-05	0.000242	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—JAK2—Crohn's disease	1.07e-05	0.000232	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TYK2—Crohn's disease	1.06e-05	0.000229	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—JAK2—Crohn's disease	1.01e-05	0.000219	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	9.79e-06	0.000212	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—Crohn's disease	9.35e-06	0.000202	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—Crohn's disease	9.31e-06	0.000201	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	9.23e-06	0.0002	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	9.07e-06	0.000196	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—Crohn's disease	8.82e-06	0.000191	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—Crohn's disease	8.78e-06	0.00019	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	8.65e-06	0.000187	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	7.9e-06	0.000171	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	7.88e-06	0.00017	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STAT3—Crohn's disease	7.87e-06	0.00017	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	7.51e-06	0.000162	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	7.51e-06	0.000162	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STAT3—Crohn's disease	7.42e-06	0.000161	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	6.86e-06	0.000148	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	6.52e-06	0.000141	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	6.35e-06	0.000137	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	5.51e-06	0.000119	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—Crohn's disease	5.5e-06	0.000119	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—Crohn's disease	5.18e-06	0.000112	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—Crohn's disease	4.44e-06	9.59e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—Crohn's disease	3.85e-06	8.33e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—Crohn's disease	3.75e-06	8.1e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.28e-06	7.09e-05	CbGpPWpGaD
